identified SNVs and indels using GATK Haplotypecaller (McKenna et al. 2010) . In 2 standard GATK Best Practices workflow (DePristo et al. 2011 ) for human genomes, 3 high-confidence SNVs and indels are filtered through a statistical learning approach 4 using training datasets of variants derived from population-scale data from the 1000 5
Genomes Project (The 1000 Genomes Project Consortium et al. 2010) or the 6
International HapMap Project (International HapMap Consortium 2005) . Since similar 7 datasets are not available for marmosets, to identify high-confidence SNVs and indels, 8 we adopted our own statistical approach. Briefly, we analyzed the distributions of the 9 following parameters (QD, FS, MQ, MQRankSum, ReadPosRankSum) in the raw 1 0 outputs from GATK Haplotypecaller and determined a series of appropriate filtering 1 1 thresholds for SNVs and indels separately (see Materials and Methods). 1 2
Through this approach, we identified a total of ~3.75M SNVs (2.23M 1 3 heterozygous, 1.52M homozygous) and 0.82M indels (0.43M heterozygous, 0.38M 1 4 homozygous) (Table 1, Figure 2a , EVA accession PRJEB27676); 33% of SNVs and 35% 1 5 of indels are intragenic, and 0.73% of SNVs and 0.41% of indels are within protein 1 6 coding exons (Table 1) . Furthermore, we also identified long genomic stretches 1 7 exhibiting continuous homozygosity by using a Hidden Markov Model (HMM) adopted 1 8 from Adey and colleagues (Adey et al. 2013) . In cj367, continuous stretches of 1 9 chromosome 1, 2, 4, 6, 7, 9, 12, 13, 14, 15, and 22 show long continuous stretches of 2 0 homozygosity that likely resulted from inbreeding (Figure 2a , Table S1 ).
We then haplotype-phased the identified SNVs and indels in cj367 by performing 1 10X Genomics Chromium linked-read library preparation and sequencing (Zheng et al. 2 2016; Marks et al. 2018) . Post sequencing analysis showed that approximately 1.26 ng 3 or 381 genomic equivalents of high molecular weight (HMW) genomic DNA fragments 4 (average size 36 kb, 66.2% > 20kb, 14.3% >100kb) were partitioned into approximately 5 1.27 million droplets and uniquely barcoded (16 bp) ( Table 1) . The linked-read library 6 was sequenced (2ൈ151 bp) to 30.4ൈ genome coverage with half of the reads coming 7 from HMW DNA molecules with at least 30 linked-reads (N50 Linked-Reads per 8
Molecule) (Table 1) . We estimate the actual physical coverage (C F ) to be 128.5ൈ. 9
Coverage of the mean insert by sequencing (C R ) is 8,520 bp (284bp ൈ 30 linked-reads) 1 0 or 23.7% of the average input DNA fragment size, thus the overall sequencing coverage 1 1 Figure S1, Figure 2a ), and poorly phased regions correspond to regions 1 6 exhibiting continuous homozygosity (Table S1, Figure 2a , EVA accession 1 7 PRJEB27676). 1 8
Cj367 genome-specific and allele-specific CRISPR targets 1 9
We identified 44,590 targets in cj367 genome suitable for allele-specific CRISPR 2 0 targeting (Table S2 ). Phased variant sequences (including reverse complement) that 2 1 differ by >1 bp between the alleles were extracted to identify all possible CRISPR 2 2 targets by pattern searching for [G, C, or A]N 20 GG (see Materials and Methods). Only conserved high-quality targets were retained by using a selection method previously 1 described and validated (Sunagawa et al. 2016) . We took the high-quality target 2 filtering process further by taking the gRNA function and structure into account. Targets  3 with multiple exact matches, extreme GC fractions, and those with TTTT sequence 4 (which might disrupt the secondary structure of gRNA) were removed. Furthermore, we 5 used the Vienna RNA-fold package (Lorenz et al. 2011) to identify gRNA secondary 6 structure and eliminated targets for which the stem loop structure for Cas9 recognition is 7 not able to form (Nishimasu et al. 2014 ). Finally, we calculated the off-target risk score 8 using the tool as described for this purpose (Ran et al. 2013) . A very strict off-target 9 threshold score was chosen in which candidates with a score below 75 were rejected to 1 0 ensure that all targets are as reliable and as specific as possible. 1 1
CRISPR/Cas9 in marmoset ESC 1 2
In order to test whether CRISPR/Cas9 technology would be suitable to create 1 3
transgenic marmoset models, we tested whether sgRNA-guided CRISPR entry was 1 4 possible in cj367. After transfecting cj367 marmoset ESCs with plasmids carrying 1 5 dCas9-GFP (Chen et al. 2013 ) and using sgRNA sequences that target telomeres, we 1 6 successfully located dCas9-GFP fluorescence from telomeres within the nuclei of live 1 7 marmoset ESCs (three nuclei shown; Fig. 3a-c) , demonstrating that the Cas9 nuclease 1 8
can indeed enter the nuclease and possibly edit the genome in a targeted fashion. 1 9
Teratoma assay demonstrate that pluripotency of ESC remains unchanged after dCas9-2 0 GFP transfection (data not shown).
One of the many advantages of using the common marmoset as a model to 1 study human disease is that its physiology, brain structure, and aspects of behavior 2 more closely resemble that of humans (Okano et al. 2012; Kishi et al. 2014) . The 3 creation of pluripotent marmoset SC lines provides a platform on which to study 4 molecular and cellular patterns typical of the species. Traditionally, marmoset ESC 5 lines have been derived from the inner cell mass of blastocysts, and all of the surviving 6 lines had been female (Thomson et al. 1996; Sasaki et al. 2005; Debowski et al. 2016) . In addition to revealing these biological characteristics of cj367 that are especially 2 1 applicable for neuroscience research, our results allow researchers to perform genome-2 2 editing in cj367 using CRISPR/Cas9 in a "personalized" and allele-specific manner. Our haplotype-resolved whole-genome characterization of cj367 also provides a reference 1 for all future functional genomic and epigenomics studies, such as RNA-seq, DNA 2 methylation analysis, or ChIP-seq, carried out using cj367 or derivative cell 3 lines/animals. Taken together, our data provide a valuable resource for the primate 4 transgenic research community in this post-genome era. 5
The recent successes in using CRISPR-Cas9 to disrupt specific genes such as ESCs, which suggests that the Cas9 nuclease can indeed enter the nucleus and edit 1 5 the genome in a sequence-directed manner. Furthermore, this not only demonstrates 1 6 the relative ease of porting existing gene-editing methodologies but also the exciting 1 7 future feasibility of creating genetic models of human disorders that provide new 1 8 insights only possible in NHP models (Capitanio and Emborg 2008; Zahs and Ashe 1 9 2010).
0
With the imminent application of CRISPR-Cas9 for marmosets on the horizon, it 2 1 is important to have genome characterizations of the NHP ESC and iPSC lines that are 2 2 being distributed to various research labs across the world from primate cell repositories.
It is now widely recognized that sequence variants can confound the intended on-target 1 and off-target sites of the gRNAs especially when appropriate controls are lacking 2 (Pinello et al. 2016). The CRISPR system relies on Watson and Crick base pairing to 3 mediate genomic editing, thus it is not surprising that genetic sequence variation can 4 widely affect its efficiency. By taking advantage of the extensive documentation of 5 human genetic variation, efforts have been made to elucidate the impact of genetic 6 variation on CRISPR targeting (Canver et al. 2018) . Importantly, it has also been 7 recognized that this effect on CRISPR-targeting efficiency due to genetic sequence 8 variation can be leveraged to make cell line-specific or allele-specific CRISPR edits for 9 various studies (Zhou et al. 2018 ). The need for such resources to facilitate the use of 1 0 CRISPR-Cas9 in primate research has already been voiced in the literature (Luo et al. 1 1 2016). Here, we performed the first whole-genome characterization for an established 1 2 NHP ESC line and the first haplotype-phasing for a marmoset genome. We also 1 3 determined the CRISPR-targeting sites suitable for allele-specific editing for cj367 1 4 (Table S2 ). Our haplotype-resolved whole-genome analysis as well as a list of 1 5 CRISPR-targeting sites will not only be useful for cj367 in particular but also for future 1 6 cell lines and animal models derived from the same genome as cj367. 1 7
Possessing the unique property among mammals of routinely producing dizygotic 1 8 twins that exchange hematopoietic stem cells in utero, all marmoset animals are 1 9 naturally chimeric (Benirschke et al. 1962 ). While such chimerism will affect analyses of 2 0 DNA samples obtained from developed animals, it does not affect our whole-genome of 2 1
ESCs since the cj367 ESC line was derived before the developmental stage where the 2 2 differentiation and exchange of hematopoietic stem cells can occur.
Another important aspect of whole-genome characterization is the analyses of 1 structural and copy-number variation. The current quality of the marmoset reference 2 genome assembly does not allow for confident mapping of structural variants 3 (Marmoset Genome Sequencing and Analysis Consortium 2014; Sato et al. 2015) . 4
Improvements in this regard are greatly needed. This also applies to other NHP 5 genome assemblies as well (Luo et al. 2016) . 6
Our whole-genome analysis of marmoset ESC line cj367 also allows for the 7 accurate and confident interpretation of functional genomics datasets. Recently, RNA-8 seq experiments have been carried out in marmoset ESCs that show that overall 9 expression patterns differ between cell lines derived from different animals under the 1 0 same culturing conditions (Debowski et al. 2016) , which could be a result of different 1 1 genetic backgrounds. Furthermore, the expression patterns of various marmoset ESC 1 2 lines more closely resemble primed pluripotency states rather than naïve states even 1 3 though these cells passed all criteria for expression of established pluripotent markers 1 4 (Debowski et al. 2016) . This suggests that the culturing methods established for human 1 5 pluripotent cells are not directly applicable to marmoset cells. Importantly, these results 1 6 also suggest that functional genomic and epigenomics studies such as RNA-seq, 1 7 ATAC-seq, and whole-genome bisulfite sequencing could be adopted as a tool to 1 8 screen for and identify marmoset ESC lines that may exhibit true naïve pluripotency 1 9
states. 2 0
Materials and Methods 2 1
Cell Culture 2 2
The frozen marmoset ESC starter cultures were removed from the liquid nitrogen tank (-1 80 °C) and placed in a 37 °C water bath until thawed. Cells were transferred to a 15 mL 2 centrifuge tube and 10 mL DMEM/F12 (Thermo Scientific, SH30023.01) was added 3 drop-wise in order to minimize bubble formation. The mixture was centrifuged at 1000 4 RPM for 3 min. The supernatant was aspirated and the process was repeated allowing 5 the cells to be washed once more with another 10 mL DMEM/F12. Cells were re-6 suspended in 1 mL of medium, which was added to a single well of Matrigel 7 hESC-qualified Matrix (BD Biosciences, 356234)-coated BioLite 6-well clear multi-dish 8 (Thermo Scientific, 130184) and incubated at 37 °C and 5% CO 2 . The medium in each 9
well was changed daily and the cells were passaged every 4 to 5 days. For passaging, 1 0 cells were washed with DPBS (Life Technologies, 14190-144), dissociated with 1 1 Accutase (Stem Cell Technologies, 7920), and added to fresh medium on a new plate 1 2 and/or added to freezing medium for storage. 1 3
Media ingredients: 1 4
• E8 Medium (Thermo Scientific, A15169-01) 1 5
• E8 Supplement (Thermo Scientific, A15171-01) 1 6
• Glutamax (Life Technologies, 35050-061) 1 7
• Lipid Concentrate (Life Technologies, 11905-031) 1 8
• Nodal (R&D Systems, 3218-ND) 1 9
• Glutathione (Sigma, G4251) 2 0
Freezing medium: 20% DMSO (Thermo Fischer, 20688) solution (DMSO + 2 1 DMEM/F12). 2 2
Differentiating marmoset ESCs into iNs
Accutase and plated at 250,000, 200,000, 150,000, and 100,000 cells per well. One-2 day post-passage, a single well was transfected with the 3 viral vectors as described in 3 the two-week iN protocol (Zhang et al. 2013 ). The vectors were acquired from the 4 Genome Virus and Vector Core (GVVC) at Stanford Neuroscience Institute 5 (neuroscience.stanford.edu). The protocol was stopped prior to plating on mouse glia in 6 order to achieve immature cortical glutamatergic neurons. Following transfection, cells 7 were subjected to puromycin and doxycyclin selection and then monitored for a 8 minimum of 7 days. For human iPSCs, full differentiation is usually completed at day 7. 9
The marmoset ESCs required 10 to 11 days (the day of passage is defined as "day 0") 1 0 to achieve full differentiation. 1 1
CRISPR-Cas9 Transfection 1 2
Marmoset cj367 embryonic stem cells were seeded onto a 35mm glass bottom 1 3 microwell dish (MatTek) that was coated with 0.083 μ g of BD Matrigel (BD Biosciences) 1 4 per well. While the cells were maintained for approximately 48 hours to recover and 1 5 return to their typical growth rate, they were visually scanned under a light microscope 1 6 and manually dissected to remove any patches of spontaneously differentiated cells. At 1 7 70% confluence on the 35mm dish, the cells were transfected simultaneously with 1 8
Addgene plasmids pSLQ1658-dCas9-EGFP and pSLQ1651-sgTelomere(F+E). We 1 9
followed Invitrogen's protocol for the Lipofectamine LTX transfection reagent (Thermo 2 0
Fisher Scientific) using 5μL with 1μg of DNA from each plasmid for one 35mm dish.
1
The lipid-DNA complexes were adjusted to a final volume of 100μL using OptiMEM 2 2 (Thermo Fisher Scientific) and added to the marmoset cells for six hours. Following six hours of incubation, medium was changed to its original E8 formula. Five hours before 1 imaging, cells were incubated with a photostable DMEM (MEMO EMD Millipore) 2 supplemented with ROCK inhibitor to reduce photobleaching effects of the E8 media. 3
Finally, an additional medium change using MEMO was done immediately before 4 imaging. 5
Nuclear imaging 6
Marmoset cell nuclei were imaged with an OMX BLAZE 3D-Structured Illumination 7
Microscope (Applied Precision, GE). Cells were transferred to a modified stage adaptor 8 held at 37 o C and 5% CO 2 . 1μm z-stacks (0.125μm intervals) were taken at 100x 9 magnification (U-PLANAPO 100X SIM objective N.A. 1.42) with a 488nm laser using 1 0
DeltaVision OMX acquisition software (version 3.70.9622.0, GE) and deconvolved with 1 1 SoftWoRx 7.0.0 software (Deltavision) before maximum projections were made for the 1 2
figures (Fiji/ImageJ). 1 3
Illumina WGS 1 4
Marmoset ESC (cj367) genomic DNA was extracted using the Qiagen DNeasy Blood & 1 5
Tissue Kit (Cat.D No. 69504) and quantified using the Qubit dsDNA HS Assay Kit 1 6 (Invitrogen, Waltham, MA, USA). DNA purity was verified (OD260/280 > 1.8; 1 7 OD260/230 > 1.5) using NanoDrop (Thermo Scientific, Waltham, MA, USA). Afterwards, 1 8
DNA was sheared to 200 bp to 850 bp (average size = 400 bp) using the Covaris S2 1 9 instrument (Covaris, Woburn, MA, USA). DNA was then concentrated to a volume of 50 2 0 µL using the DNA Clean & Concentrator kit (Cat. No. D4013) from Zymo Research 2 1 (Irvine, CA, USA). One short-insert WGS library was constructed using the Kapa Hyper 2 2
Library-size selection (420 bp to 1 kb) was carried out on the BluePippin instrument 2 using the R2 marker on a 1.5% dye-free cassette from Sage Science (Beverly, MA, 3 USA). WGS library-size selection was then verified using the 2100 Bioanalyzer DNA 4 1000 Kit (Agilent Technologies, Santa Clara, CA, USA). The WGS library was then 5 sequenced (2ൈ150 bp) on two lanes of the Illumina HiSeq 4000 to achieve >600 million 6 pass-filter paired-end reads. 7
Determining SNVs and Indels 8
Paired-end reads from the two lanes of Illumina HiSeq 4000 were combined and aligned 9 to the Callithrix jacchus genome (GenBank accession GCA_000004665.1) using BWA- ReadPosRankSum > -8.0). 1 5
Identifying genomic regions exhibiting continuous homozygosity 1 6
A Hidden Markov Model (HMM) was used to identify genomic regions exhibiting 1 7 continuous homozygosity. The HMM is designed with two states: homogzyous and 1 8 heterozygous. We used the hard-filtered SNVs we derived from GATK HaplotypeCaller, 1 9 and filtered again for GQ > 30 and QUAL > 50. The genome was split into 25 kb bins; 2 0 heterozygous and homozygous SNVs were tallied for each bin, and bins with <25 SNVs 2 1 were removed. A bin was classified as heterozygous if >50% of the SNVs within the bin 2 2 are heterozygous, otherwise it was classified as homozygous. This classification was used as the HMM emission sequence. The HMM was initialized with the same initiation 1 and transition probabilities (Prob=10E-8) (Adey et al., 2013) , the Viterbi algorithm was 2 used to estimate a best path, and adjacent homozygous intervals were merged. 3
10X Genomics linked-read library and sequencing 4
Marmoset ESC (cj367) genomic DNA was extracted using the MagAttract HMW DNA 5
Kit from Qiagen (Cat. No. 67563) (Hilden, Germany). The extracted genomic DNA was 6 verified to be of HMW (average size >30 kb) using using field-inversion gel 7 electrophoresis on the Pippin Pulse System (Sage Science, Beverly, MA, USA). DNA 8 was then diluted to 1 ng/µl to be used as input for the 10x Genomics (Pleasanton, CA, 9 USA) Chromium system (Zheng et al. 2016; Marks et al. 2018) in which HMW DNA 1 0 fragments are partitioned into >1 million droplets in emulsion, uniquely barcoded (16 bp) 1 1 within each droplet, and subjected to random priming and isothermal amplification 1 2 following standard manufacturer's protocol. The barcoded DNA molecules were then 1 3 released from the droplets and converted to a linked-read library in which each library 1 4 molecule has a 16 bp "HMW fragment barcode". The final linked-read library (8 cycles 1 5 of PCR amplification) was quantified using the Kapa Library Quantification Kit (Cat. No. 1 6 KK4824) from Kapa Biosystems (Woburn, MA, USA) and diluted to 4 nM. Sequencing 1 7 (2ൈ151 bp) was performed on the Illumina NextSeq 500 using the NextSeq 500/550 1 8
High Output v2 kit (Cat. No. FC-404-2004) to achieve >30ൈ genomic coverage. 1 9
Haplotype phasing using linked-reads 2 0
Read-pairs i.e. linked-reads, that come from the same HMW DNA fragment carry the 2 1 same "HMW fragment barcode" on Read 1. Virtual long-reads that are representative of 2 2 the sequences of the original HMW genomic DNA fragments can be generated by clustering of linked-reads with identical barcodes. This process allows for the haplotype 1 phasing of heterozygous SNVs and Indels. Paired-end linked-reads (median insert size 2 368 bp, duplication rate 5.39%, Q30 Read1 75.6%, Q30 Read2 68.4%) were aligned to 3 Callithrix jacchus genome (GenBank accession GCA_000004665.1) (alignment rate 4 87.3%, mean coverage 30.4x, zero coverage 0.938%) and analyzed using the Long 5
Ranger Software (version 2.1.3) from 10x Genomics (Zheng et al. 2016; Marks et al. 6 2018) (Pleasanton, CA, USA). Genome indexing was performed prior to alignment 7 using the Long Ranger mkref module. Since Long Ranger mkref requires less than 500 8 contigs, we concatenated contigs in GCA_000004665.1 to meet this requirement. 9
Reference gaps and repeat regions, downloaded from UCSC Genome Browser 1 0 (Karolchik et al. 2004; Kuhn et al. 2013) , were excluded from the analysis. Phasing was 1 1 performed by specifying the set of pre-determined and filtered heterozygous SNVs and 1 2 Indels from using GATK (see above) and formatted using mkvcf from Long Ranger 1 3 (version 2.1.5). Phasing analysis was performed using the Long Ranger wgs module. 1 4
Allele-specific CRISPR targets 1 5
To identify allele-specific CRISPR targets, we started by extracting variants that 1 6 satisfy the following properties from Dataset S2 (phased variants): 1 7 1. They passed quality control (VCF field 'Filter' is equal to "PASS") 1 8 2. They are phased (VCF field 'GT' uses "|" as separator rather than "/") 1 9
3. The alleles are heterozygous (e.g. "0|1" or "1|0", but not "1|1") 2 0 4. The difference between the alleles is > 1 bp (to ensure target specificity) 2 1
For the 704,571 variants that satisfy these four properties, we extracted the two 2 2 haplotype sequences (maximum length: 595). We only worked with the sequences that were present in the phased genotype. Extracted sequences were tagged them 1 according to their haplotype, for instance: 2
• If the sequence in the 'Ref' field was "GTA", the 'Alt' field sequence was "TA", 3 and phasing was "0|1" i.e. Haplotype_1|Haplotype_2", the sequence containing 4 "GTA" was tagged "1" for Haplotype 1 and the sequence containing "TA" was 5 tagged "2" for Haplotype 2. 6
• If the 'Ref' field was sequence "GTA", the 'Alt' field was "TA,GCTA", phasing was 7 "1|2", the sequence containing "TA" is tagged "1", the sequence containing 8 "GCTA" was tagged "2" (and the sequence containing "GTA" was not used) 9
A regular expression, RegEx, was used to extract all potential CRISPR targets from 1 0 these sequences (i.e. all sequences that matched a [G, C, or A]N 20 GG pattern and 1 1 those for which the reverse-complement matched this pattern). This yielded 720,239 1 2 candidates, which were then filtered to retain only high-quality targets. The process is 1 3 adapted from a selection method previously described and validated (Sunagawa et al. 1 4 2016) and has already been used for more than 20 genes (Tatsuki et al. 2016) . A high-1 5 quality candidate gRNA needs to target a unique site. All the candidates that have 1 6 multiple exact matches in hg19 (irrespective of location) were identified using Bowtie2 1 7 (Langmead and Salzberg 2012) and removed. We also removed targets with extreme 1 8 GC content (>80% or <20%), and targets that contain TTTT, which tends to break the 1 9
gRNA's secondary structure. We also used the Vienna RNA-fold package (Lorenz et al. 2014), except if the folding energy was above -18 (indicating that the "incorrectly-folded" structure is unstable). Finally, we evaluated the off-target risk score using our own 1 implementation of the Zhang tool (Ran et al. 2013) . To ensure that all targets are as 2 reliable and specific as possible, we used a very strict threshold and rejected 3 candidates with an off-target risk score less than 75. Candidates that satisfy all these 4 requirements are considered high quality. For each candidate, we report the location of 5 the variant (chromosome and position), the haplotype ( "1" or "2" from the "Phased 6
Genotype" column i.e. "Haplotype_1 | Haplotype_2"), the gRNA target sequence, its 7 position relative to the start of the variant, its orientation, its off-target score, and the 8 genomic element targeted (gene or enhancer). Note that the position relative to the start 9 of the variant is for the 5'-most end of the target respective to the genome: if the target 1 0 is 5'-3', it is its 5' end; if a target was extracted on the reverse complement, it is its 3' 1 1 end. 
